Department of Orthopedics, Division of Spine, NYU Langone Orthopedic Hospital, New York, NY, USA
Financial Disclosure: The following financial relationships outside of this work were reported as follows: Dr. Buckland, Corin, Pfizer, and Nuvasive; Jeffrey A. Goldstein, Altus Spine, Globus Medical, Regeneration Technologies, Zimmer, Nuvasive, Johnson & Johnson, and St. Teresa Medical, with board memberships on ISASS, Journal ISASS, Spine, Spine Surgery Today, and The Spine Journal; Dr. Errico, Fastenetix, Metronic, Paradigm Spine, Pfizer, and K2M, with board memberships on Harms Study Group and International Spine Study Group; Dr. Fischer, Expert Connect and Stryker. The other authors have no disclosures. No funding was received for this study. The authors report no conflicts of interest in regard to this work.
Correspondence to Bradley C. Johnson, MD, NYU Medical Center – NYU Langone Orthopedic Hospital, Department of Orthopaedic Surgery, Division of Spine, 310 East 17th Street, Suite 400, New York, NY 10003 Tel: +(212) 598-6509; fax: +(212) 598-6581; e-mail: [email protected].